Global Nimodipine Sustained Release Tablets Market Growth 2023-2028

Report ID: 1457403 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Nimodipine Sustained Release Tablets Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Nimodipine Sustained Release Tablets by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Nimodipine Sustained Release Tablets by Country/Region, 2017, 2022 & 2028
    2.2 Nimodipine Sustained Release Tablets Segment by Type
        2.2.1 30mg/Piece
        2.2.2 60mg/Piece
        2.2.3 Others
    2.3 Nimodipine Sustained Release Tablets Sales by Type
        2.3.1 Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)
        2.3.2 Global Nimodipine Sustained Release Tablets Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Nimodipine Sustained Release Tablets Sale Price by Type (2017-2022)
    2.4 Nimodipine Sustained Release Tablets Segment by Application
        2.4.1 Hospital
        2.4.2 Pharmacy
        2.4.3 Others
    2.5 Nimodipine Sustained Release Tablets Sales by Application
        2.5.1 Global Nimodipine Sustained Release Tablets Sale Market Share by Application (2017-2022)
        2.5.2 Global Nimodipine Sustained Release Tablets Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Nimodipine Sustained Release Tablets Sale Price by Application (2017-2022)
3 Global Nimodipine Sustained Release Tablets by Company
    3.1 Global Nimodipine Sustained Release Tablets Breakdown Data by Company
        3.1.1 Global Nimodipine Sustained Release Tablets Annual Sales by Company (2020-2022)
        3.1.2 Global Nimodipine Sustained Release Tablets Sales Market Share by Company (2020-2022)
    3.2 Global Nimodipine Sustained Release Tablets Annual Revenue by Company (2020-2022)
        3.2.1 Global Nimodipine Sustained Release Tablets Revenue by Company (2020-2022)
        3.2.2 Global Nimodipine Sustained Release Tablets Revenue Market Share by Company (2020-2022)
    3.3 Global Nimodipine Sustained Release Tablets Sale Price by Company
    3.4 Key Manufacturers Nimodipine Sustained Release Tablets Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Nimodipine Sustained Release Tablets Product Location Distribution
        3.4.2 Players Nimodipine Sustained Release Tablets Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nimodipine Sustained Release Tablets by Geographic Region
    4.1 World Historic Nimodipine Sustained Release Tablets Market Size by Geographic Region (2017-2022)
        4.1.1 Global Nimodipine Sustained Release Tablets Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Nimodipine Sustained Release Tablets Annual Revenue by Geographic Region
    4.2 World Historic Nimodipine Sustained Release Tablets Market Size by Country/Region (2017-2022)
        4.2.1 Global Nimodipine Sustained Release Tablets Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Nimodipine Sustained Release Tablets Annual Revenue by Country/Region
    4.3 Americas Nimodipine Sustained Release Tablets Sales Growth
    4.4 APAC Nimodipine Sustained Release Tablets Sales Growth
    4.5 Europe Nimodipine Sustained Release Tablets Sales Growth
    4.6 Middle East & Africa Nimodipine Sustained Release Tablets Sales Growth
5 Americas
    5.1 Americas Nimodipine Sustained Release Tablets Sales by Country
        5.1.1 Americas Nimodipine Sustained Release Tablets Sales by Country (2017-2022)
        5.1.2 Americas Nimodipine Sustained Release Tablets Revenue by Country (2017-2022)
    5.2 Americas Nimodipine Sustained Release Tablets Sales by Type
    5.3 Americas Nimodipine Sustained Release Tablets Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Nimodipine Sustained Release Tablets Sales by Region
        6.1.1 APAC Nimodipine Sustained Release Tablets Sales by Region (2017-2022)
        6.1.2 APAC Nimodipine Sustained Release Tablets Revenue by Region (2017-2022)
    6.2 APAC Nimodipine Sustained Release Tablets Sales by Type
    6.3 APAC Nimodipine Sustained Release Tablets Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Nimodipine Sustained Release Tablets by Country
        7.1.1 Europe Nimodipine Sustained Release Tablets Sales by Country (2017-2022)
        7.1.2 Europe Nimodipine Sustained Release Tablets Revenue by Country (2017-2022)
    7.2 Europe Nimodipine Sustained Release Tablets Sales by Type
    7.3 Europe Nimodipine Sustained Release Tablets Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Nimodipine Sustained Release Tablets by Country
        8.1.1 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Nimodipine Sustained Release Tablets Revenue by Country (2017-2022)
    8.2 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Type
    8.3 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Nimodipine Sustained Release Tablets
    10.3 Manufacturing Process Analysis of Nimodipine Sustained Release Tablets
    10.4 Industry Chain Structure of Nimodipine Sustained Release Tablets
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Nimodipine Sustained Release Tablets Distributors
    11.3 Nimodipine Sustained Release Tablets Customer
12 World Forecast Review for Nimodipine Sustained Release Tablets by Geographic Region
    12.1 Global Nimodipine Sustained Release Tablets Market Size Forecast by Region
        12.1.1 Global Nimodipine Sustained Release Tablets Forecast by Region (2023-2028)
        12.1.2 Global Nimodipine Sustained Release Tablets Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Nimodipine Sustained Release Tablets Forecast by Type
    12.7 Global Nimodipine Sustained Release Tablets Forecast by Application
13 Key Players Analysis
    13.1 Bionpharma
        13.1.1 Bionpharma Company Information
        13.1.2 Bionpharma Nimodipine Sustained Release Tablets Product Offered
        13.1.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Bionpharma Main Business Overview
        13.1.5 Bionpharma Latest Developments
    13.2 Arbor Pharmaceuticals
        13.2.1 Arbor Pharmaceuticals Company Information
        13.2.2 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered
        13.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Arbor Pharmaceuticals Main Business Overview
        13.2.5 Arbor Pharmaceuticals Latest Developments
    13.3 Sofgen Pharmaceuticals
        13.3.1 Sofgen Pharmaceuticals Company Information
        13.3.2 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered
        13.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sofgen Pharmaceuticals Main Business Overview
        13.3.5 Sofgen Pharmaceuticals Latest Developments
    13.4 Pharmaceutics International
        13.4.1 Pharmaceutics International Company Information
        13.4.2 Pharmaceutics International Nimodipine Sustained Release Tablets Product Offered
        13.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Pharmaceutics International Main Business Overview
        13.4.5 Pharmaceutics International Latest Developments
    13.5 Heritage Pharmaceuticals
        13.5.1 Heritage Pharmaceuticals Company Information
        13.5.2 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered
        13.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Heritage Pharmaceuticals Main Business Overview
        13.5.5 Heritage Pharmaceuticals Latest Developments
    13.6 Bayer Vital
        13.6.1 Bayer Vital Company Information
        13.6.2 Bayer Vital Nimodipine Sustained Release Tablets Product Offered
        13.6.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Bayer Vital Main Business Overview
        13.6.5 Bayer Vital Latest Developments
    13.7 Wuhan HITECK Biopharmaceutical
        13.7.1 Wuhan HITECK Biopharmaceutical Company Information
        13.7.2 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Offered
        13.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Wuhan HITECK Biopharmaceutical Main Business Overview
        13.7.5 Wuhan HITECK Biopharmaceutical Latest Developments
    13.8 Qilu Pharmaceutical
        13.8.1 Qilu Pharmaceutical Company Information
        13.8.2 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
        13.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Qilu Pharmaceutical Main Business Overview
        13.8.5 Qilu Pharmaceutical Latest Developments
    13.9 Yabao Pharmaceutical Group
        13.9.1 Yabao Pharmaceutical Group Company Information
        13.9.2 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Offered
        13.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Yabao Pharmaceutical Group Main Business Overview
        13.9.5 Yabao Pharmaceutical Group Latest Developments
    13.10 Sihuan Pharmaceutical
        13.10.1 Sihuan Pharmaceutical Company Information
        13.10.2 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
        13.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Sihuan Pharmaceutical Main Business Overview
        13.10.5 Sihuan Pharmaceutical Latest Developments
    13.11 Jiangsu Kanion Pharmaceutical
        13.11.1 Jiangsu Kanion Pharmaceutical Company Information
        13.11.2 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
        13.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Jiangsu Kanion Pharmaceutical Main Business Overview
        13.11.5 Jiangsu Kanion Pharmaceutical Latest Developments
    13.12 Shandong Yunmen Pharmaceutical
        13.12.1 Shandong Yunmen Pharmaceutical Company Information
        13.12.2 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
        13.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Shandong Yunmen Pharmaceutical Main Business Overview
        13.12.5 Shandong Yunmen Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Nimodipine Sustained Release Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Nimodipine Sustained Release Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 30mg/Piece
    Table 4. Major Players of 60mg/Piece
    Table 5. Major Players of Others
    Table 6. Global Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)
    Table 7. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)
    Table 8. Global Nimodipine Sustained Release Tablets Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2017-2022)
    Table 10. Global Nimodipine Sustained Release Tablets Sale Price by Type (2017-2022) & (US$/Unit)
    Table 11. Global Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)
    Table 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)
    Table 13. Global Nimodipine Sustained Release Tablets Revenue by Application (2017-2022)
    Table 14. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2017-2022)
    Table 15. Global Nimodipine Sustained Release Tablets Sale Price by Application (2017-2022) & (US$/Unit)
    Table 16. Global Nimodipine Sustained Release Tablets Sales by Company (2020-2022) & (K Units)
    Table 17. Global Nimodipine Sustained Release Tablets Sales Market Share by Company (2020-2022)
    Table 18. Global Nimodipine Sustained Release Tablets Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Nimodipine Sustained Release Tablets Revenue Market Share by Company (2020-2022)
    Table 20. Global Nimodipine Sustained Release Tablets Sale Price by Company (2020-2022) & (US$/Unit)
    Table 21. Key Manufacturers Nimodipine Sustained Release Tablets Producing Area Distribution and Sales Area
    Table 22. Players Nimodipine Sustained Release Tablets Products Offered
    Table 23. Nimodipine Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Nimodipine Sustained Release Tablets Sales by Geographic Region (2017-2022) & (K Units)
    Table 27. Global Nimodipine Sustained Release Tablets Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Nimodipine Sustained Release Tablets Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Nimodipine Sustained Release Tablets Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Nimodipine Sustained Release Tablets Sales by Country/Region (2017-2022) & (K Units)
    Table 31. Global Nimodipine Sustained Release Tablets Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Nimodipine Sustained Release Tablets Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Nimodipine Sustained Release Tablets Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Nimodipine Sustained Release Tablets Sales by Country (2017-2022) & (K Units)
    Table 35. Americas Nimodipine Sustained Release Tablets Sales Market Share by Country (2017-2022)
    Table 36. Americas Nimodipine Sustained Release Tablets Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Nimodipine Sustained Release Tablets Revenue Market Share by Country (2017-2022)
    Table 38. Americas Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)
    Table 39. Americas Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)
    Table 40. Americas Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)
    Table 41. Americas Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)
    Table 42. APAC Nimodipine Sustained Release Tablets Sales by Region (2017-2022) & (K Units)
    Table 43. APAC Nimodipine Sustained Release Tablets Sales Market Share by Region (2017-2022)
    Table 44. APAC Nimodipine Sustained Release Tablets Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Nimodipine Sustained Release Tablets Revenue Market Share by Region (2017-2022)
    Table 46. APAC Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)
    Table 47. APAC Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)
    Table 48. APAC Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)
    Table 49. APAC Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)
    Table 50. Europe Nimodipine Sustained Release Tablets Sales by Country (2017-2022) & (K Units)
    Table 51. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country (2017-2022)
    Table 52. Europe Nimodipine Sustained Release Tablets Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country (2017-2022)
    Table 54. Europe Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)
    Table 55. Europe Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)
    Table 56. Europe Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)
    Table 57. Europe Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Country (2017-2022) & (K Units)
    Table 59. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Nimodipine Sustained Release Tablets Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)
    Table 63. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)
    Table 65. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Nimodipine Sustained Release Tablets
    Table 67. Key Market Challenges & Risks of Nimodipine Sustained Release Tablets
    Table 68. Key Industry Trends of Nimodipine Sustained Release Tablets
    Table 69. Nimodipine Sustained Release Tablets Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Nimodipine Sustained Release Tablets Distributors List
    Table 72. Nimodipine Sustained Release Tablets Customer List
    Table 73. Global Nimodipine Sustained Release Tablets Sales Forecast by Region (2023-2028) & (K Units)
    Table 74. Global Nimodipine Sustained Release Tablets Sales Market Forecast by Region
    Table 75. Global Nimodipine Sustained Release Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Nimodipine Sustained Release Tablets Sales Forecast by Country (2023-2028) & (K Units)
    Table 78. Americas Nimodipine Sustained Release Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Nimodipine Sustained Release Tablets Sales Forecast by Region (2023-2028) & (K Units)
    Table 80. APAC Nimodipine Sustained Release Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Nimodipine Sustained Release Tablets Sales Forecast by Country (2023-2028) & (K Units)
    Table 82. Europe Nimodipine Sustained Release Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Nimodipine Sustained Release Tablets Sales Forecast by Country (2023-2028) & (K Units)
    Table 84. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Nimodipine Sustained Release Tablets Sales Forecast by Type (2023-2028) & (K Units)
    Table 86. Global Nimodipine Sustained Release Tablets Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Nimodipine Sustained Release Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Nimodipine Sustained Release Tablets Sales Forecast by Application (2023-2028) & (K Units)
    Table 90. Global Nimodipine Sustained Release Tablets Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global Nimodipine Sustained Release Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Bionpharma Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 94. Bionpharma Nimodipine Sustained Release Tablets Product Offered
    Table 95. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 96. Bionpharma Main Business
    Table 97. Bionpharma Latest Developments
    Table 98. Arbor Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 99. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered
    Table 100. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 101. Arbor Pharmaceuticals Main Business
    Table 102. Arbor Pharmaceuticals Latest Developments
    Table 103. Sofgen Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 104. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered
    Table 105. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 106. Sofgen Pharmaceuticals Main Business
    Table 107. Sofgen Pharmaceuticals Latest Developments
    Table 108. Pharmaceutics International Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 109. Pharmaceutics International Nimodipine Sustained Release Tablets Product Offered
    Table 110. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 111. Pharmaceutics International Main Business
    Table 112. Pharmaceutics International Latest Developments
    Table 113. Heritage Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 114. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered
    Table 115. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 116. Heritage Pharmaceuticals Main Business
    Table 117. Heritage Pharmaceuticals Latest Developments
    Table 118. Bayer Vital Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 119. Bayer Vital Nimodipine Sustained Release Tablets Product Offered
    Table 120. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 121. Bayer Vital Main Business
    Table 122. Bayer Vital Latest Developments
    Table 123. Wuhan HITECK Biopharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 124. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Offered
    Table 125. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 126. Wuhan HITECK Biopharmaceutical Main Business
    Table 127. Wuhan HITECK Biopharmaceutical Latest Developments
    Table 128. Qilu Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 129. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
    Table 130. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 131. Qilu Pharmaceutical Main Business
    Table 132. Qilu Pharmaceutical Latest Developments
    Table 133. Yabao Pharmaceutical Group Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 134. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Offered
    Table 135. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 136. Yabao Pharmaceutical Group Main Business
    Table 137. Yabao Pharmaceutical Group Latest Developments
    Table 138. Sihuan Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 139. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
    Table 140. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 141. Sihuan Pharmaceutical Main Business
    Table 142. Sihuan Pharmaceutical Latest Developments
    Table 143. Jiangsu Kanion Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 144. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
    Table 145. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 146. Jiangsu Kanion Pharmaceutical Main Business
    Table 147. Jiangsu Kanion Pharmaceutical Latest Developments
    Table 148. Shandong Yunmen Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
    Table 149. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Offered
    Table 150. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 151. Shandong Yunmen Pharmaceutical Main Business
    Table 152. Shandong Yunmen Pharmaceutical Latest Developments
List of Figures
    Figure 1. Picture of Nimodipine Sustained Release Tablets
    Figure 2. Nimodipine Sustained Release Tablets Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Nimodipine Sustained Release Tablets Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Nimodipine Sustained Release Tablets Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Nimodipine Sustained Release Tablets Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 30mg/Piece
    Figure 10. Product Picture of 60mg/Piece
    Figure 11. Product Picture of Others
    Figure 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Type in 2021
    Figure 13. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2017-2022)
    Figure 14. Nimodipine Sustained Release Tablets Consumed in Hospital
    Figure 15. Global Nimodipine Sustained Release Tablets Market: Hospital (2017-2022) & (K Units)
    Figure 16. Nimodipine Sustained Release Tablets Consumed in Pharmacy
    Figure 17. Global Nimodipine Sustained Release Tablets Market: Pharmacy (2017-2022) & (K Units)
    Figure 18. Nimodipine Sustained Release Tablets Consumed in Others
    Figure 19. Global Nimodipine Sustained Release Tablets Market: Others (2017-2022) & (K Units)
    Figure 20. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)
    Figure 21. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application in 2021
    Figure 22. Nimodipine Sustained Release Tablets Revenue Market by Company in 2021 ($ Million)
    Figure 23. Global Nimodipine Sustained Release Tablets Revenue Market Share by Company in 2021
    Figure 24. Global Nimodipine Sustained Release Tablets Sales Market Share by Geographic Region (2017-2022)
    Figure 25. Global Nimodipine Sustained Release Tablets Revenue Market Share by Geographic Region in 2021
    Figure 26. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2017-2022)
    Figure 27. Global Nimodipine Sustained Release Tablets Revenue Market Share by Country/Region in 2021
    Figure 28. Americas Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)
    Figure 29. Americas Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)
    Figure 30. APAC Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)
    Figure 31. APAC Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)
    Figure 32. Europe Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)
    Figure 33. Europe Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)
    Figure 34. Middle East & Africa Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)
    Figure 35. Middle East & Africa Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)
    Figure 36. Americas Nimodipine Sustained Release Tablets Sales Market Share by Country in 2021
    Figure 37. Americas Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2021
    Figure 38. United States Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Canada Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Mexico Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Brazil Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 42. APAC Nimodipine Sustained Release Tablets Sales Market Share by Region in 2021
    Figure 43. APAC Nimodipine Sustained Release Tablets Revenue Market Share by Regions in 2021
    Figure 44. China Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Japan Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 46. South Korea Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Southeast Asia Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 48. India Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Australia Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country in 2021
    Figure 51. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2021
    Figure 52. Germany Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 53. France Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 54. UK Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Italy Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Russia Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Country in 2021
    Figure 58. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2021
    Figure 59. Egypt Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 60. South Africa Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Israel Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Turkey Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 63. GCC Country Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Manufacturing Cost Structure Analysis of Nimodipine Sustained Release Tablets in 2021
    Figure 65. Manufacturing Process Analysis of Nimodipine Sustained Release Tablets
    Figure 66. Industry Chain Structure of Nimodipine Sustained Release Tablets
    Figure 67. Channels of Distribution
    Figure 68. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Nimodipine Sustained Release Tablets Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Nimodipine Sustained Release Tablets Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Nimodipine Sustained Release Tablets Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports